Internal Medicine, Pulmonary Disease · Atlanta, GA
NPI
1902127723
Since 2010
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
5673 Peachtree Dunwoody Rd, Suite 502
Atlanta, GA, 30342
Phone (404) 251-1700
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
1,422 services
Medicare patients, 2024
401
Average age 75
Drug cost, 2024
$3.6M
1,890 prescriptions
Company payments, 2025
$56K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Colin Swenson was code 99215 (office e&m - established), 244 times for 174 patients. In total Colin Swenson billed 1,422 services in 33 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 244 | 174 | $119.74 | $29K |
| 94729 Pulmonary Function Testing | Office | 169 | 166 | $28.88 | $4,881 |
| 94726 Pulmonary Function Testing | Office | 167 | 165 | $29.49 | $4,924 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 160 | 138 | $12.48 | $1,996 |
| 94375 Pulmonary Function Testing | Office | 150 | 140 | $23.84 | $3,576 |
| 95012 Pulmonary | Office | 115 | 106 | $12.97 | $1,491 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 98 | 52 | $24.82 | $2,433 |
| 94060 Pulmonary Function Testing | Office | 79 | 76 | $21.37 | $1,688 |
| 94618 Pulmonary Function Testing | Office | 55 | 55 | $23.12 | $1,272 |
| 99205 Office E&M - New | Office | 36 | 36 | $153.52 | $5,527 |
| 99214 Office E&M - Established | Office | 29 | 28 | $85.15 | $2,469 |
| 99291 Critical Care E&M | Facility | 24 | 17 | $165.85 | $3,980 |
| 99223 Hospital E&M - Initial | Facility | 18 | 18 | $134.91 | $2,428 |
| 94375 Pulmonary Function Testing | Facility | 17 | 17 | $10.93 | $186 |
By year: 2022 $111K for 1,327 services; 2023 $80K for 993 services; 2024 $71K for 1,422 services.
Medicare prescription drug claims, 2024
In 2024, the drug Colin Swenson prescribed most often to Medicare patients was Azithromycin, with 239 prescriptions and refills. In total Colin Swenson wrote 1,890 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azithromycin Generic | 239 | 561 | 88 | $5,146 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 159 | 199 | 61 | $4,736 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 92 | 122 | 20 | $76K |
| Ethambutol Hcl Generic | 89 | 199 | 33 | $9,283 |
| Dupixent Pen Dupilumab | 77 | 77 | Under 11 | $288K |
| Breo Ellipta Fluticasone/Vilanterol | 76 | 125 | 16 | $48K |
| Montelukast Sodium Generic | 61 | 169 | 22 | $735 |
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 51 | 51 | Under 11 | $1.3M |
| Advair Hfa Fluticasone Propion/Salmeterol | 51 | 68 | 11 | $27K |
| Prednisone Generic | 49 | 81 | 24 | $353 |
| Rifampin Generic | 47 | 127 | 16 | $6,950 |
| Levofloxacin Generic | 46 | 46 | 40 | $347 |
| Dupixent Syringe Dupilumab | 39 | 39 | Under 11 | $144K |
| Azelastine Hcl Generic | 38 | 47 | 11 | $1,009 |
| Zemaira Alpha-1-Proteinase Inhibitor | 37 | 37 | Under 11 | $374K |
Brand drugs: - claims; generic drugs: 1,011 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Colin Swenson $56K ($56K in general payments such as food, travel and fees) from 9 companies. The largest payer was Insmed, Inc. with $37K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.